NCT00521430 - Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2008

Study Completion Date

September 30, 2008

Conditions

LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesNonmalignant NeoplasmUnspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL

anti-thymocyte globulin

DRUG

busulfan

DRUG

cyclosporine

DRUG

fludarabine phosphate

DRUG

methotrexate

DRUG

methylprednisolone

PROCEDURE

allogeneic hematopoietic stem cell transplantation

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

138-736

Asan Medical Center - University of Ulsan College of Medicine, Seoul